UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protective Efficacy of a Second Pneumococcal Conjugate Vaccine against Pneumococcal Acute Otitis Media in Infants and Children: Randomized, Controlled Trial of a 7-Valent Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine in 1666 Children

Clinical infectious diseases, 2003-11, Vol.37 (9), p.1155-1164

2003

Volltextzugriff (PDF)

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

The New England journal of medicine, 1996-06, Vol.334 (26), p.1697-1702

1996

Volltextzugriff (PDF)

Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

Clinical infectious diseases, 1995-09, Vol.21 (3), p.536-541

1995

Volltextzugriff (PDF)

Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

Science (American Association for the Advancement of Science), 1995-10, Vol.270 (5234), p.299-302

1995

Volltextzugriff (PDF)

Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

The Journal of infectious diseases, 1998-06, Vol.177 (6), p.1664-1673

1998

Volltextzugriff (PDF)

Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis

Genes and immunity, 2007-06, Vol.8 (4), p.334-343

2007

Volltextzugriff (PDF)

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial

The New England journal of medicine, 1991-02, Vol.324 (7), p.429-436

1991

Volltextzugriff (PDF)

Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

The Journal of infectious diseases, 1996-12, Vol.174 (6), p.1176-1184

1996

Volltextzugriff (PDF)

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits

The Lancet (British edition), 1994-11, Vol.344 (8932), p.1273-1276

1994

Volltextzugriff (PDF)

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

The Journal of infectious diseases, 1995-06, Vol.171 (6), p.1576-1585

1995

Volltextzugriff (PDF)

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

Infection and Immunity, 1996-09, Vol.64 (9), p.3833-3844

1996

Volltextzugriff (PDF)

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines

Infection and Immunity, 1994-10, Vol.62 (10), p.4440-4444

1994

Volltextzugriff (PDF)

Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes

The Journal of infectious diseases, 1996-08, Vol.174 (2), p.361-366

1996

Volltextzugriff (PDF)

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers

Infection and Immunity, 1996-10, Vol.64 (10), p.4074-4077

1996

Volltextzugriff (PDF)

Choice of bacteria in animal models of sepsis

Infection and immunity, 1993-07, Vol.61 (7), p.2741-2747

1993

Volltextzugriff (PDF)

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1

The Journal of infectious diseases, 1995-10, Vol.172 (4), p.1126-1129

1995

Volltextzugriff (PDF)

Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1 α protects mice from lethal bacterial infection

The Journal of experimental medicine, 1989-06, Vol.169 (6), p.2021-2027

1989

Volltextzugriff (PDF)

Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites

The American journal of tropical medicine and hygiene, 1993-08, Vol.49 (2), p.166-173

1993

Volltextzugriff (PDF)

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis : A phase III, randomized, double-blind, placebo-controlled, multicenter trial

Critical care medicine, 1997-07, Vol.25 (7), p.1115-1124

1997

Volltextzugriff (PDF)

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization

Vaccine, 1997-06, Vol.15 (8), p.804-807

1997

Volltextzugriff (PDF)

Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective

The Journal of infectious diseases, 1995-07, Vol.172 (1), p.180-185

1995

Volltextzugriff (PDF)

Human Cytotoxic T Lymphocytes Against the Plasmodium falciparum Circumsporozoite Protein

Proceedings of the National Academy of Sciences - PNAS, 1991-04, Vol.88 (8), p.3300-3304

1991

Volltextzugriff (PDF)

A Noncovalent Complex Vaccine Prepared with Detoxified Escherichia coli J5 (Rc Chemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein Produces Protective Antibodies against Gram-Negative Bacteremia

The Journal of infectious diseases, 1996-05, Vol.173 (5), p.1157-1163

1996

Volltextzugriff (PDF)

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity

Vaccine, 1995, Vol.13 (16), p.1488-1494

1995

Volltextzugriff (PDF)

Update on Research and Development Pipeline: Tuberculosis Vaccines

Clinical infectious diseases, 2010-05, Vol.50 (Supplement-3), p.S178-S183

2010

Volltextzugriff (PDF)

1 – 25 von 703

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(520)
Mit Volltextzugriff
(641)

Publikationsform

Sprache

Englisch
(702)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(268)
Life Sciences & Biomedicine
(155)
Humans
(128)
Biological And Medical Sciences
(117)
Physics
(115)
Physical Sciences
(104)
Immunology
(94)
Infectious Diseases
(85)
Microbiology
(80)
Animals
(79)
Male
(65)
Female
(64)
Medical Sciences
(63)
Fundamental And Applied Biological Sciences. Psychology
(59)
Adult
(57)
Physics Of Elementary Particles And Fields
(53)
Physics, Multidisciplinary
(52)
Physics, Particles & Fields
(49)
Astronomy & Astrophysics
(46)
Elementary Particles
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Protective Efficacy of a Second Pneumococcal Conjugate Vaccine against Pneumococcal Acute Otitis Media in Infants and Children: Randomized, Controlled Trial of a 7-Valent Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine in 1666 Children

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial

Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines

Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers

Choice of bacteria in animal models of sepsis

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1

Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1 α protects mice from lethal bacterial infection

Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis : A phase III, randomized, double-blind, placebo-controlled, multicenter trial

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization

Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective

Human Cytotoxic T Lymphocytes Against the Plasmodium falciparum Circumsporozoite Protein

A Noncovalent Complex Vaccine Prepared with Detoxified Escherichia coli J5 (Rc Chemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein Produces Protective Antibodies against Gram-Negative Bacteremia

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity

Update on Research and Development Pipeline: Tuberculosis Vaccines

Suchergebnisse filtern